Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei

Immunology

Volumn 130, Issue 3, 2010, Pages 352-362

  Chiba, Yukihide ^a,b   Shida, Kan ^b,c   Nagata, Satoru ^a,b   Wada, Mariko ^a,b   Bian, Lei ^b   Wang, Chongxin ^b   Shimizu, Toshiaki ^a   Yamashiro, Yuichiro ^b   Kiyoshima Shibata, Junko ^c   Nanno, Msanobu ^c   Nomoto, Koji ^b,c  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Lactobacillus casei; Mouse; Peyer's patch; Probiotics; Spleen cell; Th1 cells

Indexed keywords

CD11B ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOMODULATION; INTERFERON PRODUCTION; LACTOBACILLUS CASEI; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-6; LACTOBACILLUS CASEI; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PEYER'S PATCHES; PROBIOTICS; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953529888     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03204.x     Document Type: Article

References (54)

1. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005 307 : 1915 1920.
2. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004 28 : 405 440.
3. Bjorksten B. The intrauterine and postnatal environments. J Allergy Clin Immunol 1999 104 : 1119 1127.
4. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003 361 : 512 519.
5. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007 62 : 1223 1236.
6. Joint Food and Agriculture Organization of the United Nations/World Health Organization Expert Consultation 2001. Health and nutritional properties in food including powder milk with live lactic acid bacteria. Available at http://www.who.int/foodsafety/publications/fs-management/en/probiotics.pdf.
7. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006 100 : 1171 1185.
8. Morais MB, Jacob CM. The role of probiotics and prebiotics in pediatric practice. J Pediatr (Rio J) 2006 82 : S189 97.
9. Gill H, Prasad J. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 2008 606 : 423 454.
10. Shida K, Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends Immunol 2008 29 : 565 573.
11. Cross ML. Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Applied Immunol Rev 2002 3 : 115 125.
12. Nomoto K. Prevention of infections by probiotics. J Biosci Bioeng 2005 100 : 583 592.
13. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004 126 : 1620 1633.
14. Kalliomaki MA, Isolauri E. Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am 2004 24 : 739 752. viii.
15. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005 54 : 317 320.
16. Shida K, Kiyoshima-Shibata J, Nagaoka M, Watanabe K, Nanno M. Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J Dairy Sci 2006 89 : 3306 3317.
17. Niers LE, Timmerman HM, Rijkers GT et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005 35 : 1481 1489.
18. Foligne B, Nutten S, Grangette C et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007 13 : 236 243.
19. Shida K, Makino K, Morishita A et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998 115 : 278 287.
20. Mohamadzadeh M, Olson S, Kalina WV et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 2005 102 : 2880 2885.
21. Smits HH, Engering A, van der Kleij D et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005 115 : 1260 1267.
22. Niers LE, Hoekstra MO, Timmerman HM et al. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol 2007 149 : 344 352.
23. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003 16 : 658 672.
24. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008 121 : 116 121. e11.
25. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005 307 : 1920 1925.
26. Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 2005 206 : 149 159.
27. Kelsall BL, Rescigno M. Mucosal dendritic cells in immunity and inflammation. Nat Immunol 2004 5 : 1091 1095.
28. O'Mahony L, O'Callaghan L, McCarthy J et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 2006 290 : G839 45.
29. Honda K, Takeda K. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol 2009 2 : 187 196.
30. Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990 250 : 1720 1723.
31. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005 174 : 3237 3246.
32. Zeuthen LH, Fink LN, Frokiaer H. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology 2008 123 : 197 208.
33. Feleszko W, Jaworska J, Rha RD et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007 37 : 498 505.
34. Foligne B, Zoumpopoulou G, Dewulf J et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2007 2 : e313.
35. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 2008 84 : 468 476.
36. Iwabuchi N, Takahashi N, Xiao JZ, Miyaji K, Iwatsuki K. In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria. Microbiol Immunol 2007 51 : 649 660.
37. Zeuthen LH, Christensen HR, Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol 2006 13 : 365 375.
38. Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, Oliveira SC. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol 2008 180 : 1080 1087.
39. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000 68 : 3581 3586.
40. Karlsson H, Larsson P, Wold AE, Rudin A. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect Immun 2004 72 : 2671 2678.
41. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007 8 : 345 350.
42. Niess JH, Leithauser F, Adler G, Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol 2008 180 : 559 568.
43. Atarashi K, Nishimura J, Shima T et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008 455 : 808 812.
44. Tanabe S, Kinuta Y, Saito Y. Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 2008 22 : 181 185.
45. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994 12 : 227 257.
46. Baken KA, Ezendam J, Gremmer ER et al. Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int J Food Microbiol 2006 112 : 8 18.
47. Yasui H, Kiyoshima J, Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 2004 11 : 675 679.
48. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995 27 : 104 109.
49. Shida K, Takahashi R, Iwadate E et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 2002 32 : 563 570.
50. Matsumoto S, Hara T, Hori T et al. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 2005 140 : 417 426.
51. Kato I, Endo-Tanaka K, Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 1998 63 : 635 644.
52. Matsuzaki T, Nagata Y, Kado S, Uchida K, Kato I, Hashimoto S, Yokokura T. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 1997 105 : 643 649.
53. Mike A, Nagaoka N, Tagami Y et al. Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice. Clin Exp Immunol 1999 117 : 368 375.
54. Drisko JA, Giles CK, Bischoff BJ. Probiotics in health maintenance and disease prevention. Altern Med Rev 2003 8 : 143 155.